Cart
0

Automated Radiosynthesis Modules Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_161761
Pages: 36
Nov 2016 | 1820 Views
 
Author's : Onkar Sumant
Tables: 21
Charts: 8
 

Automated Radiosynthesis Module Market Overview:

Global Automated Radiosynthesis Module Market was valued at $20 million in 2015, and is expected to reach $32 million by 2022, supported by a CAGR of 6.6%. Radiosynthesis modules are available as automated equipment for decentralized settings for the formulation and production of radiotracers. Majority of the radiotracers are manufactured in the centralized laboratories and radiopharmaceutical units. This scenario has few imitations such as it reduces the scope for customization of production of radiotracer and increases the time gap for the radiotracer to reach the end users. As radiotracers have limited half-life, its performance decreases when employed for diagnosis or therapy administration. Automated radiosynthesis modules are simple to set up and easy to use and offers the scope for customization of the radiotracers. This in turn drives the performance of the diagnostic and therapy monitoring activities for the end users.

Automated Radiosynthesis Modules Market

Get more information on this report : Request Sample Pages

Rise in incidence of chronic diseases and increase in adoption of PET/SPECT imaging fuel the automation of radiotracer production process. Further, the supply of these products is anticipated to become streamlined and effective, owing to the improved cGMP guideline from the FDA. Manufacturers are expected to gain additional income by diversifying their product offering to cater to the needs of new markets. Premium pricing is projected to remain a source of concern and limit the rate of adoption of these module; however, the availability of funds and grants from the government is expected to offset this constraint.

Increase in Adoption of Pet & Spect as Vital Diagnostic Tools

The global burden for chronic diseases is increasing worldwide at an alarming rate. To control this situation, the global healthcare industry focuses on early diagnosis of disease to provide prompt treatment. This will facilitate reducing the global burden of chronic diseases such as cardiovascular diseases, chronic obstructive pulmonary disorder, cancer, and others. Diagnostics tools such as PET and SPECT are adopted globally to reduce the rapidly increasing chronic diseases, which provide high-resolution quality imaging, simplifying the complex diagnosis process. This equipment uses PET radiopharmaceuticals with short lifetime radioactive isotopes that are manufactured using fully automated radiosynthesis process. The radiopharmaceuticals are incorporated in the PET/CT/SPECT scanners to improve the utility of tomographic imaging diagnostics methods that are available commercially.

High Cost is a Barrier for Adoption of Automated Radiosynthesis Module

The manual radiosynthesis module causes exposure to radiation, which can pose as a possible harm to the radiopharmacist. Thus, the new era nuclear medicines and manufacturers of radiolabeled compounds are keen on adoption of automated radiosynthesis module. The average cost of automated radiosynthesis module is more than $50,000. Although these modules provide high accuracy, the high cost of installation and servicing limits its growth in the commercial market. In spite of the fact that there has been a global mandate to use automated radiosynthesis module to reduce radiation exposure to the operator in the clinical setting, the cost pose to be a barrier. The high start-up cost is projected to prohibit the users from the adoption of automated radiosynthesis module, which will further limit the growth of the market at a global platform.

Funding and Grants Create Market Opportunity Worldwide

The automated radiosynthesis module provides high yield and quality radiopharmaceuticals for multiple applications. Along with high-quality end products, the module also facilitates no radiation exposure to the operator, promoting the adoption of automated synthesis module at a commercial platform. Cost is a major obstacle that may hinder the growth of the global automated radiosynthesis module market. To overcome this constraint and promote the usage of automated radiosynthesis module, there are funding and grands provided by government as well as private institution. For instance, the Department of Energy provided approximately $1 million phase II grant under the Small Business Innovation Research (SBIR) program to develop microscale technology for rapid, simple synthesis of PET probes. These probes are radiopharmaceuticals that are manufactured using automated radiosynthesis module. Moreover, a study was published on May 2015 related to the radiosynthesis of 6-deoxy-6[18F]fluorosucrose using automated synthesis to understand its utility for the study of in vivo sucrose transport in maize (Zea mays) leaves.

Key Benefits

  • The study offers a detailed analysis along with market dynamics.
  • A quantitative analysis of the current trends market and future estimations from 2014 to 2020 is provided, enabling all the stakeholders to capitalize the prevailing and emerging opportunities of the market.
  • Key market players and their market share analysis in studied in the report.
  • Strategic analysis of the key leaders and their business strategies within the market are provided, which assist stakeholders to make more informed business decisions.
  • Porters Five Forces analysis examines the competitive structure of the global market and also provides a deeper understanding of the influence factors for market entry and market expansion.

Automated Radiosynthesis Module Market Key Segments:

By Geography (Value and Volume)

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

The key players that operate in the market include:

  • GE Healthcare
  • Siemens Healthcare
  • IBA Radiopharma Solutions
  • Optimized Radiochemical Applications
  • Synthra GmbH
  • Eckert & Ziegler Group

Other market players in value chain include:

  • Sumitomo Corp
  • Scintomics GmbH
  • Sofie Biosciences
  • Trasis S.A
  • Raytest Isotopenmessgerte GmbH
  • Posi-Med LLC
 

Chapter: 1 RESEARCH METHODOLOGY

1.1 Secondary research
1.2 Primary research
1.3 Analyst tools and models

Chapter: 2 MARKET OVERVIEW

2.1 Market definition and scope
2.2 Market dynamics

2.2.1 Drivers

2.2.1.1 Increasing adoption of PET & SPECT as vital diagnostic tools
2.2.1.2 Diverse applications of radiopharmaceuticals in medical industry

2.2.2 Restraints

2.2.2.1 High cost is a barrier for adoption of automated radiosynthesis module

2.2.3 Opportunities

2.2.3.1 Funding and grants create market opportunity worldwide

2.3 Porter’s Five Forces Analysis

2.3.1 Bargaining Power of Suppliers
2.3.2 Bargaining Power of Buyers
2.3.3 Threat of New Entrants
2.3.4 Threat of Substitutes
2.3.5 Competitive Rivalry

2.4 Market Share Analysis, 2015

Chapter: 3 WORLD AUTOMATED RADIOSYNTHESIS MODULES MARKET, BY VALUE AND VOLUME

3.1 Market size and forecast

Chapter: 4 WORLD AUTOMATED RADIOSYNTHESIS MODULES MARKET, BY GEOGRAPHY

4.1 North America

4.1.1 Market size and forecast

4.2 Asia-Pacific

4.2.1 Market size and forecast

4.3 Europe

4.3.1 Market size and forecast

4.4 LAMEA

4.4.1 Market size and forecast

Chapter: 5 COMPANY PROFILES

5.1 GE Healthcare

5.1.1 Company Overview
5.1.2 Company Snapshot
5.1.3 Operating Business Segments
5.1.4 Business Performance
5.1.5 Key Strategic Moves and Developments

5.2 Siemens Healthcare

5.2.1 Company Overview
5.2.2 Company Snapshot
5.2.3 Operating Business Segments
5.2.4 Business Performance
5.2.5 Key Strategic Moves and Developments

5.3 IBA Radiopharma Solutions

5.3.1 Company Overview
5.3.2 Company Snapshot
5.3.3 Operating Business Segments
5.3.4 Business Performance
5.3.5 Key Strategic Moves and Developments

5.4 Optimized Radiochemical Applications

5.4.1 Company Overview
5.4.2 Company Snapshot
5.4.3 Operating Business Segments
5.4.4 Business Performance
5.4.5 Key Strategic Moves and Developments

5.5 Synthra GmbH

5.5.1 Company Overview
5.5.2 Company Snapshot
5.5.3 Operating Business Segments
5.5.4 Business Performance
5.5.5 Key Strategic Moves and Developments

5.6 Eckert

5.6.1 Company Overview
5.6.2 Company Snapshot
5.6.3 Operating Business Segments
5.6.4 Business Performance
5.6.5 Key Strategic Moves and Developments

5.7 Ziegler Group

5.7.1 Company Overview
5.7.2 Company Snapshot
5.7.3 Operating Business Segments
5.7.4 Business Performance
5.7.5 Key Strategic Moves and Developments

List of Figures

FIG. 1 TOP FACTORS IMPACTING GLOBAL ENERGY STORAGE SYSTEMS MARKET
FIG. 2 NUMBER OF INSTALLATION OF PET SCANNER WORLDWIDE IN 2014
FIG. 3 NUMBER OF INSTALLATION OF PET SCANNER WORLDWIDE IN 2015
FIG. 4 ESTIMATED NEW CASES OF CANCER WORLDWIDE IN MALE IN 2012
FIG. 5 ESTIMATED NEW CASES OF CANCER WORLDWIDE IN MALE IN 2012
FIG. 6 GLOBAL ESTIMATED AVAILABILITY OF RADIOTHERAPY, 2013
FIG. 7 PORTER’S FIVE FORCES ANALYSIS
FIG. 8 MARKET SHARE ANALYSIS, 2015 (% SHARE)

List of Tables

TABLE 1 GLOBAL STATISTICS FOR CHRONIC DISEASES
TABLE 2 FDA-RECOGNIZED RADIOPHARMACEUTICALS FOR PET
TABLE 3 WORLD AUTOMATED RADIOSYNTHESIS MODULES MARKET, 2014-2022 (NUMBER OF UNITS) ($ MILLION)
TABLE 4 NORTH AMERICA AUTOMATED RADIOSYNTHESIS MODULES MARKET, 2014-2022 (NUMBER OF UNITS) ($ MILLION)
TABLE 5 ASIA-PACIFIC AUTOMATED RADIOSYNTHESIS MODULES MARKET, 2014-2022 (NUMBER OF UNITS) ($ MILLION)
TABLE 6 EUROPE AUTOMATED RADIOSYNTHESIS MODULES MARKET, 2014-2022 (NUMBER OF UNITS) ($ MILLION)
TABLE 7 LAMEA AUTOMATED RADIOSYNTHESIS MODULES MARKET, 2014-2022 (NUMBER OF UNITS) ($ MILLION)
TABLE 8 GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 9 GE HEALTHCARE: OPERATING SEGMENTS
TABLE 10 SIEMENS HEALTHCARE: COMPANY SNAPSHOT
TABLE 11 SIEMENS HEALTHCARE: OPERATING SEGMENTS
TABLE 12 IBA RADIOPHRAMA: COMPANY SNAPSHOT
TABLE 13 IBA RADIOPHARMA: OPERATING SEGMENTS
TABLE 14 OPTIMIZED RADIOCHEMICAL: COMPANY SNAPSHOT
TABLE 15 OPTIMIZED READIOCHEMICAL: OPERATING SEGMENTS
TABLE 16 SYNTHRA: COMPANY SNAPSHOT
TABLE 17 SYNTHRA: OPERATING SEGMENTS
TABLE 18 ECKERT: COMPANY SNAPSHOT
TABLE 19 ECKERT: OPERATING SEGMENTS
TABLE 20 ZIEGLER: COMPANY SNAPSHOT
TABLE 21 ZIEGLER: OPERATING SEGMENTS

List of Tables

TABLE 1 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 2 WORLD ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 3 ANGIOPLASTY BALLOONS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 4 WORLD ANGIOPLASTY STENTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 5 WORLD CORONARY STENTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 6 ANGIOPLASTY STENTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 7 WORLD ANGIOPLASTY CATHETERS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 8 ANGIOPLASTY CATHETERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 9 WORLD ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 10 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 11 TYPES OF IVC FILTERS AVAILABLE IN THE MARKET
TABLE 12 WORLD INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 13 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 14 WORLD PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 15 PLAQUE MODIFICATION DEVICES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 16 WORLD HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 17 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 18 WORLD ACCESSORIES MARKET, BY TYPE, 2014–2022 ($MILLION)
TABLE 19 ACCESSORIES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 20 INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
TABLE 21 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 22 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 23 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 24 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 25 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 26 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 27 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014–2022 ($MILLION)
TABLE 28 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014–2022 ($MILLION)
TABLE 29 ABBOTT: COMPANY SNAPSHOT
TABLE 30 ABBOTT: OPERATING SEGMENTS
TABLE 31 B. BRAUN: COMPANY SNAPSHOT
TABLE 32 B. BRAUN: OPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 35 BARD: COMPANY SNAPSHOT
TABLE 36 BARD: OPERATING SEGMENTS
TABLE 37 CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 38 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 39 COOK MEDICAL: COMPANY SNAPSHOT
TABLE 40 COOK MEDICAL: DIVISIONS
TABLE 41 MEDTRONIC: COMPANY SNAPSHOT
TABLE 42 MEDTRONIC: OPERATING SEGMENTS
TABLE 43 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 44 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 45 TERUMO: COMPANY SNAPSHOT
TABLE 46 TERUMO: OPERATING SEGMENTS
TABLE 47 SPECTRANETICS: COMPANY SNAPSHOT
TABLE 48 SPECTRANETICS: OPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Automated Radiosynthesis Modules Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $3174
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3526
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4426
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $5316
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $7414
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo